As a study participant, you play a valuable role in helping to get safe, effective drugs approved for public use.
Because you are such an important part of our studies, we have simplified the steps for participation.
This is the first step. All volunteers will be able to review the Informed Consent Form, and the program will be carefully explained by our professional medical team.
After evaluating your particular medical situation, we will invite you into our clinic for a comprehensive and complimentary physical exam.
If you meet the physical guidelines of the study, you will be asked to participate. No insurance, social security number or proof of citizenship is required.
This professional clinical study, conducted by Clinical Research LA, is a short term trial in which you will intake a promising new medication seeking FDA approval. Depending on the study you join, this medication’s use is intended to effectively treat your medical condition.
This clinical research study is a phase 2 study which means that the Phase 1 study was very promising and the FDA has approved the study to move to phase 2. Phase 1 study included human participants and saw limited adverse reaction issues.
Here is what you can expect regarding these studies:
According to the CDC, Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults. RSV infections can be dangerous for certain adults. Each year, it is estimated that more than 177,000 older adults are hospitalized and 14,000 of them die in the United States due to RSV infection. Adults at highest risk for severe RSV infection include:
Older adults who get very sick from RSV may need to be hospitalized. Some may even die. Older adults are at greater risk than young adults for serious complications from RSV because our immune systems weaken when we are older.
Our clinical research clinic has extensive experience conducting Phase II through IV clinical trials with many leading pharmaceutical companies. The facility features multiple investigator with many years in clinical research and counts over 10,000 patients. Every member of the team offers a wealth of experience, a caring personality and a commitment to ably serving the pharmaceutical industry, the community, and its patients.
Our team of clinical research investigators brings many years of research experience working at UCLA and USC. They speak English, Spanish, Italian and Farsi.
Clinical Research LA
22030 Sherman Way
Canoga Park, CA 91303
Call Toll-Free: 1-818-296-6983
Your information is private and secure. It will not be shared or spammed.